Table 4.
Relative impact of French Alzheimer disease research between the periods 2004–2008 and 2009–2013, as assessed by research output and representation in the top 1 % globally cited articles for France and the other top 5 leading EU countries
| 2004–2008 | 2009–2013 | |||||||
|---|---|---|---|---|---|---|---|---|
| Country | Output of articles | Relative citation impact | Number in top 1 % globally cited articles | Percent in top 1 % globally cited articles | Output of articles | Relative citation impact | Number in top 1 % globally cited articles | Percent in top 1 % globally cited articles |
| France | 1082 | 1.34 | 18 | 1.66 | 1836 | 1.92 | 44 | 2.40 |
| Germany | 1596 | 1.56 | 25 | 1.57 | 2316 | 2.16 | 65 | 2.81 |
| Italy | 1274 | 1.38 | 13 | 1.02 | 1797 | 1.67 | 30 | 1.67 |
| Netherlands | 720 | 1.78 | 17 | 2.36 | 1087 | 2.72 | 28 | 2.58 |
| Spain | 1001 | 1.02 | 4 | 0.40 | 1884 | 1.76 | 22 | 1.17 |
| United Kingdom | 1681 | 1.66 | 43 | 2.56 | 2294 | 2.59 | 81 | 3.53 |